Canadian Company to Produce H5N1 Flu Vaccine
Posted on: Wednesday, 30 November 2005, 09:00 CST
Canadian company to produce H5N1 flu vaccine
OTTAWA, Nov. 28 (Xinhua) -- The Canadian government and the country's flu vaccine manufacturer ID Biomedical have signed a deal that will see the company produce a prototype H5N1 flu vaccine for clinical testing.
In a statement released Monday, Health Minister Ujjal Dosanjh called the contract an important component of the country's pandemic readiness.
Under the contract, the Canadian government will pay ID Biomedical 21.2 million Canadian dollars (18 million US dollars) for a currently unspecified number of doses of H5N1 vaccine.
But the prototype vaccine will not be tested until late 2006. And the process of testing and licensing a prototype H5N1 vaccine will take another year on top of that, Dr. Theresa Tam of the Public Health Agency of Canada said Monday.
Under the deal, if a pandemic vaccine is rushed to market without undergoing the full testing and licensing process, the government will have to compensate the manufacturer for any claims that might arise if there are adverse reactions to the vaccine.
Source: Xinhua News Agency - CEIS
Related Articles
- Sinovac Completes Immunization Schedule in the Phase I Clinical Trial of Its Proprietary Avian Influenza Vaccine (H5N1)
- Canada Aims to Halve the Time to Vaccinate Whole Country in a Flu Pandemic
- Study Shows Vaccine Can Block Bird Flu Spread in Poultry
- Chicken Vaccination Can Halt Bird Flu Spread: Study
- Chicken Vaccination Can Halt Bird Flu Spread
- Unlicensed Vaccine Blamed for Bird Flu Outbreak in China's Laioning
- China Makes Progress in Developing Vaccines to Control Bird Flu: Official
- Madrid Runs Out of Flu Vaccine Due to Bird Flu Panic
- Britain Plans to Vaccinate People Against Bird Flu
- Italian AIDS Vaccine Passes First Test
 |
 |
User Comments (0)
RSS Feeds